Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.24.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2022
Cash flow from operating activities:      
Net income (loss) $ 51,403 $ (55,742) $ (111,470)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization expense 15,466 12,051 8,058
Provision for (recovery of) expected credit losses 5,906 4,079 (186)
Stock-based compensation, net of amounts capitalized 55,757 55,517 50,131
Litigation settlement 0 0 12,000
Non-cash interest paid in kind and discount amortization 0 0 3,266
Non-cash lease expense 8,352 6,588 0
Deferred income taxes (2,668) 166 235
Net amortization/accretion on marketable securities (17,009) (2,697) (1,281)
Other non-cash items, net 107 0 9
Changes in operating assets and liabilities:      
Accounts receivable (68,709) (44,751) (47,094)
Prepaid expenses and other current assets 8,675 29,092 (8,220)
Other non-current assets (25,577) (24,376) (6,764)
Accounts payable 3,325 14,463 (1,095)
Operating lease liabilities (8,019) (6,342) 0
Accrued expenses and other current liabilities (6,515) 6,688 25,510
Litigation settlement 0 (12,000) 0
Deferred revenue 49,813 41,465 43,404
Other liabilities 1,158 2,459 575
Net cash provided by (used in) operating activities 71,465 26,660 (32,922)
Cash flow from investing activities:      
Purchases of marketable securities (604,648) (816,708) (267,826)
Proceeds from sales and maturities of marketable securities 514,403 639,663 268,207
Purchases of property and equipment (8,548) (6,091) (6,148)
Capitalized internal-use software (11,777) (10,358) (6,258)
Acquisitions, net of cash acquired 0 0 (3,625)
Net cash used in investing activities (110,570) (193,494) (15,650)
Cash flow from financing activities:      
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts, commissions and other offering costs 0 0 275,973
Proceeds from issuance of common stock upon exercise of stock options 43,333 24,740 20,054
Proceeds from issuance of common stock upon ESPP purchase 7,437 10,231 7,105
Payments for repurchase of Class A common shares (26,684) 0 0
Net cash provided by financing activities 24,086 34,971 303,132
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash (939) (1,176) (1,171)
Net change in cash, cash equivalents and restricted cash (15,958) (133,039) 253,389
Cash, cash equivalents and restricted cash at beginning of period 188,387 321,426 68,037
Cash, cash equivalents and restricted cash at end of period 172,429 188,387 321,426
Supplemental disclosure of cash flow information:      
Cash paid for income taxes, net of refunds 7,647 6,644 3,458
Supplemental disclosure for non-cash investing and financing:      
Right-of-use assets obtained in exchange for operating lease liabilities 23,696 8,948 0
Accrued purchases of property and equipment 2,380 1,445 216
Stock-based compensation expense capitalized in internal-use software 2,473 2,540 696
Accrued for asset retirement obligation 117 0 0
Accrued for share repurchases 2,895 0 0
Net exercise of common stock warrants $ 0 $ 0 $ 18